An association study of 11B hydroxysteroid dehydrogenase type 1 (11HSD1) polymorphisms in Samoans with type 2 diabetes and obesity

被引：0
|
作者：
Musaad, S [1 ]
Indugula, SR [1 ]
Kaushal, R [1 ]
McGarvey, ST [1 ]
Tufa, J [1 ]
Viali, S [1 ]
Weeks, DE [1 ]
Deka, R [1 ]
机构：
[1] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2004年 / 159卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [21] Polymorphisms in the promoter of the human 11beta-hydroxysteroid dehydrogenase type 2 (11B-HSD2) gene
    Alikhani-Koupaei, R.
    Fouladkou, F.
    Fustier, F.
    Cenni, B.
    Sharma, A. M.
    Deter, H. C.
    Frey, B. M.
    Frey, F. J.
    CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 186 - 186
  • [22] 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
    Hollis, G.
    Huber, R.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01) : 1 - 6
  • [23] The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity
    Nakata, Takaya
    Fujita, Atsuko
    Umeda, Makoto
    Yoshida, Hiroaki
    Inami, Kaoru
    Masuzaki, Hiroaki
    Sawai, Hirofumi
    SPRINGERPLUS, 2016, 5 : 1 - 7
  • [24] Cortisol, 11β-hydroxysteroid dehydrogenase type 1 and central obesity
    Stewart, PM
    Tomlinson, JW
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (03) : 94 - 96
  • [25] 11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
    Wake, DJ
    Walker, BR
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2004, 215 (1-2) : 45 - 54
  • [26] 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension
    Campino, Carmen
    Carvajal, Cristian A.
    Cornejo, Javiera
    San Martin, Betty
    Olivieri, Oliviero
    Guidi, Giancesare
    Faccini, Giovanni
    Pasini, Francesco
    Sateler, Javiera
    Baudrand, Rene
    Mosso, Lorena
    Owen, Gareth I.
    Kalergis, Alexis M.
    Padilla, Oslando
    Fardella, Carlos E.
    ENDOCRINE, 2010, 37 (01) : 106 - 114
  • [27] 11β-hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension
    Carmen Campino
    Cristian A. Carvajal
    Javiera Cornejo
    Betty San Martín
    Oliviero Olivieri
    Giancesare Guidi
    Giovanni Faccini
    Francesco Pasini
    Javiera Sateler
    Rene Baudrand
    Lorena Mosso
    Gareth I. Owen
    Alexis M. Kalergis
    Oslando Padilla
    Carlos E. Fardella
    Endocrine, 2010, 37 : 106 - 114
  • [28] Glucocorticoids, 11β-hydroxysteroid dehydrogenase type 1, and visceral obesity
    Paulmyer-Lacroix, O
    Boullu-Ciocca, S
    Oliver, C
    Dutour, A
    Grino, M
    M S-MEDECINE SCIENCES, 2003, 19 (04): : 473 - 476
  • [29] 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus
    Li, Xia
    Wang, Jingli
    Yang, Qin
    Shao, Shiying
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (04) : 408 - 414
  • [30] 11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study
    Ravindra Shukla
    Asish Kumar Basu
    Biplab Mandal
    Pradip Mukhopadhyay
    Animesh Maity
    Satyam Chakraborty
    Praveen Kumar Devrabhai
    BMC Endocrine Disorders, 19
12345